2018-03-15
2018年3月15日上午，诺康达总经理陶秀梅女士，副总经理尚丽霞女士，制剂总监王卓先生会见了蒙古国最大的医药集团Monos Pharma LLC的Enkhzaya Bayaraa女士、Tula女士、国药集团王增绘先生洽谈多个仿制药品种研发及工艺技术输出合作。
On the morning of March 15th 2018, Ms. Tao Xiumei, the General Manager of Nuokangda, Ms. Shang Lixia, the Vice General Manager, and Mr. Wang Zhuo, the Formulation Director, met with Ms. Enkhzaya Bayaraa, the factory director of Monos Pharma LLC, which is the largest pharmaceutical company in Mongolia. Both parties have already reached cooperation intention of a series of generic drug R&D technology output.
总经理陶秀梅对Zaya女士一行到访诺康达表示热烈欢迎，向客人详细介绍了诺康达的发展历程、业务模式、人员团队、高质量的硬件设施保障体系和国际合作优势等。Zaya女士介绍了蒙古医疗和医药卫生现状，药品开发的一般流程，及Monos药厂生产线特点。陶总带领参观了诺康达的实验室以及移动式整粒机、摇摆制粒机、湿法制粒机、气流粉碎机、湿法混合制粒机、高效包衣机、高剪切乳化分散机、胶囊灌装机等仪器设备，Zaya女士对于诺康达的先进的硬件设施和高效的研发团队表示由衷的赞许和惊叹，期待双方合作后，诺康达能作为输出品种的技术培训基地，同时为‘一带一路’沿线国家培养医药研发的高技能人才。诺康达期待与Monos未来能将有着悠久历史的蒙药方剂进行现代化的开发，开发出符合蒙古人民用药习惯的、疗效好的药品。并且逐步将特殊医用营养以及医疗器械等多种储备项目全面向蒙古国进行技术推广和转移。
Ms.Tao Xiumei, warmly welcomed Ms. Zaya and her delegations to Nuokangda. Nuokangda’s fast development history, the business model, the team, the high-quality hardware facilities as well as the international cooperation advantages were introduced to the guests. Subsequently, Ms. Zaya introduced the medical and health conditions of Mongolia, the drug R&D process, and the production line of Monos Pharma. Then, Ms. Tao led the guests to the lab visiting the HPLC, swing granulator, the wet mixing granulator, the efficient coating machine, and high-shear emulsifying disperser, etc. Ms.Zaya showed her heartfelt praise and surprise to Nuokangda's highly advanced hardware facilities, and hope that Nuokangda can serve as a tech exporting training base for Monos Pharma after cooperation, and can train more talents in the pharmaceutical science field for countries along the “Belt and Road”. Nuokangda expects to modernize the traditional Mongolian medicine prescriptions with Monos Pharma in the future, and the developed drug will meet the habits and requirement of Mongolian people. In the future, besides the generic drug, special medical use nutrition and medical devices will gradually transfer to Mongolia.
风起扬帆正当时，四海同心逐新梦。作为人类建设命运共同体和平发展的创新之举，“一带一路”建设成效显著。诺康达深入学习“一带一路”的国家战略思想，高度践行“一带一路”的国家战略。正是得益于国家的繁荣富强，高速成长的诺康达才能有幸参与到“一带一路”的具体项目的实施过程。诺康达此次与蒙古国开展的合作项目，作为医药研发领域的“一带一路”领域的先行先试，必将会引领越来越多的医药研发以及生产企业更多地参与到国家“一带一路”的伟大事业！共同铸就团结，发展，文明，繁荣的希望之梦！
When the winds sailed, the world is moving toward a goal. As an innovative move in the development of human destiny and peaceful, “the Belt and Road” has achieved remarkable achievement. Nuokangda has thoroughly studied and then highly practiced the national strategy of “the Belt and Road ”. Thanks to the prosperity and prosperity of the country, Nuokandga has the privilege of participating in the business cooperation with Mongolia this time. The cooperation between Nuokangda and Monos Pharma, as a pioneer to implement“the Belt and Road ”strategy in the pharmaceutical science field, is very meaningful and will surely lead more and more pharmaceutical companies to participate in for the great cause of the country. Let us strive to create a unity, development, civilization, and prosperity society!
